Trial Profile
An observational study of i)mini-area-under-the-curve (mini-AUC) estimation of exposure to mycophenolic acid (MPA) in heart transplant and lung transplant recipients on mycophenolate mofetil (MMF)or Mycophenolate Sodium (Myfortic) ii) utility of salivary measurements of MPA levels in heart & lung transplant recipients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jul 2019
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Mycophenolate sodium (Primary)
- Indications Heart-lung transplant rejection; Immunosuppression
- Focus Pharmacokinetics
- 25 Jul 2019 Status changed from recruiting to completed.
- 25 Aug 2011 New trial record